Common use

Flecainide is a prescription antiarrhythmic medication belonging to Class IC of the Vaughan-Williams classification, used to treat and prevent certain types of serious irregular heartbeats that can significantly impact quality of life and cardiovascular health. If you want to buy Flecainide online, this medication — available as a Tambocor generic — is one of the most effective drugs for restoring and maintaining normal heart rhythm. Flecainide is primarily prescribed for paroxysmal supraventricular tachycardia (SVT treatment), including atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome, as well as paroxysmal atrial fibrillation (AF) in patients without significant structural heart disease. This antiarrhythmic works by slowing the conduction of electrical signals through the heart muscle, stabilizing erratic cardiac rhythms and helping the heart maintain a steady, normal beat. It is also used in selected cases for the prevention and treatment of ventricular arrhythmias when the potential benefits outweigh the risks. Flecainide is often used in the "pill-in-the-pocket" approach, where patients take a single dose at the onset of an arrhythmia episode to rapidly restore normal sinus rhythm without requiring emergency room visits.

Dosage and direction

The usual starting dose of flecainide for adults is 50 to 100 mg twice daily, taken orally at evenly spaced intervals. Your cardiologist will individualize your dose based on your specific type of arrhythmia, cardiac function, response to treatment, and results from ECG monitoring and plasma drug level assessments. Dose increases should be made gradually, typically no more than 50 mg per dose every four days, to minimize the risk of proarrhythmic effects. The maximum recommended daily dose for most indications is 300 to 400 mg. Flecainide tablets can be taken with or without food, but should be taken at the same times each day for consistent blood levels. Do not stop taking this antiarrhythmic medication abruptly or change your dose without your doctor's supervision, as sudden changes can trigger dangerous arrhythmia episodes. Regular ECG monitoring is essential throughout treatment to assess the drug's effect on cardiac conduction.

Precautions

Before you buy flecainide, inform your cardiologist about your complete cardiac history. Flecainide should be used with extreme caution — or avoided entirely — in patients with a history of heart failure, significant structural heart disease, previous myocardial infarction, or hemodynamically significant valvular disease. This Class IC antiarrhythmic may worsen existing arrhythmias or provoke new, potentially life-threatening rhythm disturbances (proarrhythmic effect), especially in patients with structural heart abnormalities or electrolyte imbalances. Regular ECG monitoring is essential during treatment initiation and dose adjustments. Electrolyte levels, particularly potassium and magnesium, should be corrected before starting flecainide therapy, as imbalances increase proarrhythmic risk. Tell your doctor about all heart conditions, pacemaker or defibrillator use, and if you are pregnant, planning pregnancy, or breastfeeding. Patients with liver or kidney impairment may require lower doses, as impaired elimination can lead to drug accumulation.

Contraindications

Flecainide is contraindicated in individuals with second- or third-degree atrioventricular (AV) block, right bundle branch block combined with left hemiblock (bifascicular block), or cardiogenic shock, unless a functioning pacemaker is in place. This Tambocor generic should not be used in chronic atrial fibrillation that has not been successfully converted to normal sinus rhythm, as it may paradoxically increase ventricular rate. Patients with known hypersensitivity to flecainide acetate or any of its components should not take this medication. It is also contraindicated in patients with Brugada syndrome, severe left ventricular dysfunction, and recent myocardial infarction (within the past 2 years) due to increased mortality risk demonstrated in clinical trials. Severe liver or kidney impairment without appropriate dose adjustment and close monitoring also represents a contraindication to flecainide use.

Possible side effect

Common side effects of flecainide include dizziness, lightheadedness, visual disturbances (such as blurred or double vision, difficulty focusing), and fatigue. Some patients may experience headache, nausea, tremor, or mild shortness of breath, particularly during the initial treatment period or after dose increases. Gastrointestinal complaints including constipation and abdominal discomfort have also been reported. Serious but less common adverse effects include new or worsened arrhythmias (proarrhythmic effect), heart block, congestive heart failure, or significant conduction delays visible on ECG. Any unusual symptoms such as rapid heartbeat, chest pain, severe dizziness, fainting, or difficulty breathing should be reported to your cardiologist immediately, as they may indicate a serious cardiovascular event requiring urgent evaluation and possible treatment adjustment.

Drug interaction

Flecainide may interact significantly with several medications that affect cardiac rhythm and drug metabolism. Digoxin levels may increase when taken with flecainide, requiring dose adjustment and monitoring. Amiodarone can raise flecainide blood levels substantially, typically necessitating a 50% dose reduction. Beta-blockers used concurrently may produce additive negative inotropic effects (reduced heart pumping strength). Drugs that affect liver enzymes, particularly CYP2D6 inhibitors like quinidine, fluoxetine, paroxetine, and cimetidine, may significantly alter flecainide metabolism and increase drug levels. Combining flecainide with other antiarrhythmic drugs can increase the risk of proarrhythmic effects and should be done only under specialist supervision. Always provide your healthcare provider with a complete list of all prescription, over-the-counter, and herbal products you are using when being treated for atrial fibrillation or SVT.

Missed dose

If you miss a dose of flecainide, take it as soon as you remember, unless it is close to your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one, as this can increase the risk of side effects and potentially dangerous changes in heart rhythm. Maintaining consistent dosing is important for effective arrhythmia management — consider using alarms or pill organizers to help maintain your routine with this antiarrhythmic medication.

Overdose

An overdose of flecainide can cause life-threatening cardiovascular emergencies including severe arrhythmias, profound hypotension (dangerously low blood pressure), dramatically slowed heart rate (bradycardia), widened QRS complex, seizures, respiratory failure, or cardiac arrest. Immediate emergency medical attention is absolutely required for any suspected flecainide overdose. Treatment typically involves hospitalization with continuous cardiac monitoring, intravenous sodium bicarbonate (to counteract sodium channel blockade), vasopressors, and supportive intensive care. Always store this Tambocor generic medication safely and securely to prevent accidental overdose.

Storage

Store flecainide tablets at room temperature (20°C to 25°C / 68°F to 77°F), protected from moisture, direct light, and excessive heat. Keep the container tightly closed and out of reach of children and pets. Do not use flecainide after the expiration date printed on the packaging. Dispose of unused antiarrhythmic medication properly according to local pharmacy regulations or medication take-back programs.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.